Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes ...

Those who took Zepbound lost on average of 50 pounds, compared to 33 pounds lost among those who took Wegovy. That’s the equivalent of ... in the diabetes drug Mounjaro. Wegovy and its diabetes ...

A new study led by Weill Cornell Medicine researchers reveals that tirzepatide (Mounjaro, Zepbound) helps people lose significantly more weight than semaglutide (Wegovy). The difference is ...

Wegovy, Mounjaro and Zepbound — are among the trade casualties in the ILA union port work stoppage. Bills of lading, the digital receipts of freight containers, show that the delivery mechanisms ...

However, Wegovy is also licensed for other conditions – such as preventing heart attacks – while the equivalent trials with Mounjaro have not been completed. A huge amount of research into ...

A major new study has found that women over 55 are leading the way in weight loss –outperforming younger users of Wegovy and Mounjaro by a significant margin. The research, conducted by Voy ...

According to new research, weight loss medications like Wegovy and Mounjaro could cut cancer risk by almost half. Co-lead author of the study, Dr Yael Wolff Sagy from Clalit Health Services in Tel ...

Customs data shows that critical medical devices and drug components for the booming new weight-loss drugs from Novo Nordisk and Eli Lilly — Ozempic, Wegovy and Mounjaro — are imported into ...